Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 894 | 794 | 698 | 937 | 669 |
| Cost of Goods | 324 | 551 | 192 | 335 | 341 |
| Gross Profit | 569 | 243 | 506 | 602 | 328 |
| Operating Expenses | 5,753 | 4,993 | 6,665 | 14,237 | 3,896 |
| Operating Income | -4,860 | -4,199 | -5,967 | -13,300 | -3,227 |
| Interest Expense | 81 | 388 | 415 | 1,063 | 4,075 |
| Other Income | -276 | -230 | 658 | -934 | 28 |
| Pre-tax Income | -5,216 | -4,817 | -5,724 | -15,298 | -7,274 |
| Net Income Continuous | -5,216 | -4,817 | -5,724 | -15,298 | -7,274 |
| Net Income | $-5,216 | $-4,817 | $-5,724 | $-15,298 | $-7,274 |
| EPS Basic Total Ops | -38,160.00 | -49,080.00 | -93,480.00 | -546,000.00 | -371,200.00 |
| EPS Basic Continuous Ops | -38,145.09 | -49,029.88 | -93,459.42 | -546,315.30 | -370,888.80 |
| EPS Diluted Total Ops | -38,160.00 | -49,080.00 | -93,480.00 | -546,000.00 | -371,200.00 |
| EPS Diluted Continuous Ops | -38,145.09 | -49,029.88 | -93,459.42 | -546,315.30 | -370,888.80 |
| EBITDA(a) | $-4,044 | $-3,267 | $-5,114 | $-11,823 | $967 |